Skip to main content
Clinical Trials/JPRN-UMIN000053934
JPRN-UMIN000053934
Not yet recruiting
未知

Cross-sectional study on metabolic fate determination of brown adipose tissue and its impact on energy homeostasis - Metabolic fate of brown fat and energy homeostasis

Tohoku University0 sites1,200 target enrollmentApril 24, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tohoku University
Enrollment
1200
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 24, 2024
End Date
March 31, 2029
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • \<FDG\-PET/CT\> 1\. Individuals with dysfunction of liver, renal, cardiovascular, respiratory, endocrine and nervous systems, or with metabolic disorders, diabetes, consciousness disorders or other disease. 2\. Individuals who regularly take medications for diabetes, hyperlipidemia or hypertension. 3\. Individuals who smoke over 21 cigarettes a day or consume alcohol more than 30g a day on average. 4\. Individuals who are pregnant or breastfeeding 5\. Individuals who are considered unsuitable for the study by investigators or medical doctor due to other reasons. \<NIR\-TRS\> 1\. Individuals with glucose intolerance, hyperlipidemia, hypertension, hyperuricemia/gout, coronary artery disease, cerebral infarction, non\-alcoholic fatty liver disease, menstrual disorder, sleep apnea syndrome, motor system disease, obesity\-related kidney disease or cardiovascular risk. 2\. Individuals with BMI 30 kg/m^2 or more. 3\. Individuals with visceral fat area over 100cm^2\. 4\. Individuals who are considered unsuitable for the study by investigators or medical doctor due to other reasons. \<Epigenome\> 1\. Individuals with dysfunction of liver, renal, cardiovascular, respiratory, endocrine and nervous systems, or with metabolic disorders, diabetes, consciousness disorders or other disease. 2\. Individuals who regularly take medications for diabetes, hyperlipidemia or hypertension. 3\. Individuals who smoke over 21 cigarettes a day or consume alcohol more than 30g a day on average. 4\. Female. 5\. Individuals who are considered unsuitable for the study by the investigators due to other reasons.

Outcomes

Primary Outcomes

Not specified

Similar Trials